Ecstasy (MDMA): a review of its possible persistent psychological effects
暂无分享,去创建一个
[1] J. V. van Gerven,et al. Cognitive performance and serotonergic function in users of ecstasy , 2000, Psychopharmacology.
[2] P. McGuire,et al. Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) , 1994, British Journal of Psychiatry.
[3] A. García-Osta,et al. Differential Regulation by Methylenedioxymethamphetamine of 5‐Hydroxytryptamine1A Receptor Density and mRNA Expression in Rat Hippocampus, Frontal Cortex, and Brainstem: The Role of Corticosteroids , 1997, Journal of neurochemistry.
[4] M. Gervin,et al. Psychosis and recreational use of MDMA (“Ecstasy”) , 1993, Irish Journal of Psychological Medicine.
[5] S. Peroutka,et al. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. , 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[6] Georg Juckel,et al. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: A new hypothesis , 1993, Biological Psychiatry.
[7] E. D. De Souza,et al. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. , 1987, The Journal of pharmacology and experimental therapeutics.
[8] K. Faull,et al. Monoamine metabolites in the cerebrospinal fluid of recreational users of 3,4-methylenedimethoxymethamphetamine (MDMA: Ecstasy , 1987 .
[9] J. Langston,et al. Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations a , 1990, Annals of the New York Academy of Sciences.
[10] G. Gerra,et al. Long-lasting effects of (±)3,4-methylene-dioxymethamphetamine (Ecstasy) on serotonin system function in humans , 2000, Biological Psychiatry.
[11] L. Seiden,et al. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys , 1989, Brain Research.
[12] M. Mishkin. Memory in monkeys severely impaired by combined but not by separate removal of amygdala and hippocampus , 1978, Nature.
[13] U. McCann,et al. Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users. , 1991, Journal of clinical psychopharmacology.
[14] P. Kelly. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) , 2000, Journal of neurology, neurosurgery, and psychiatry.
[15] Andrew C. Parrott,et al. Ecstasy (MDMA) in Recreational Users: Self‐Reported Psychological and Physiological Effects , 1997 .
[16] P. McGuire. Long term psychiatric and cognitive effects of MDMA use. , 2000, Toxicology letters.
[17] Klaus P. Ebmeier,et al. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users , 1999, British Journal of Psychiatry.
[18] L S Seiden,et al. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. , 1987, The Journal of pharmacology and experimental therapeutics.
[19] R. Cohen. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; “Ecstasy”) , 1996, Biological Psychiatry.
[20] J. Downing. The psychological and physiological effects of MDMA on normal volunteers. , 1986, Journal of psychoactive drugs.
[21] G. Gerra,et al. Serotonergic function after (±)3,4‐methylene-dioxymethamphetarnine (‘Ecstasy’) in humans , 1998, International clinical psychopharmacology.
[22] Z. Szabo,et al. In vivo detection of short‐ and long‐term MDMA neurotoxicity—a positron emission tomography study in the living baboon brain , 1998, Synapse.
[23] A. Hunter. Serotonergic involvement in learning and memory. , 1989, Biochemical Society transactions.
[24] Peroutka Sj. Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus. , 1987 .
[25] M. Conner,et al. Validating the Consumption of MDMA (3,4-Methylenedioxymethamphetamine in an examination of the behavioural effects of "ecstasy" amongst recreational users. , 1999 .
[26] G. Aghajanian,et al. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.
[27] R. Peveler,et al. Psychiatric complications of 'Ecstasy' use , 1994, Journal of psychopharmacology.
[28] Z. Szabo,et al. Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings , 1998, The Lancet.
[29] S. Peroutka. Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus. , 1987, The New England journal of medicine.
[30] R. Cohen. Subjective reports on the effects of the MDMA (‘ecstasy’) experience in humans , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[31] L S Seiden,et al. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. , 1996, NIDA research monograph.
[32] A. Parrott,et al. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. , 2000, Drug and alcohol dependence.
[33] G. Battaglia,et al. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[34] M. Colado,et al. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (`ecstasy') , 1998, Neuropharmacology.
[35] J. Richards,et al. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies. , 1996, The Journal of pharmacology and experimental therapeutics.
[36] J. Krystal,et al. Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations. , 1989, Archives of general psychiatry.
[37] A. Forsyth,et al. Places and patterns of drug use in the Scottish dance scene. , 1996, Addiction.
[38] D Lehmann,et al. Mood state and brain electric activity in Ecstasy users , 2000, Neuroreport.
[39] R. Buchert,et al. Ecstasy – long-term effects on the human central nervous system revealed by positron emission tomography , 1999, British Journal of Psychiatry.
[40] U. McCann,et al. (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals , 2000, Neuropsychobiology.
[41] R. Walsh,et al. Phenomenology and Sequelae of 3,4-Methylenedioxymethamphetamine Use , 1992, The Journal of nervous and mental disease.
[42] D. Wechsler. A Standardized Memory Scale for Clinical Use , 1945 .
[43] D. Murphy,et al. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users , 1999, Psychopharmacology.
[44] H. Nelson. A Modified Card Sorting Test Sensitive to Frontal Lobe Defects , 1976, Cortex.
[45] C. Ballard,et al. Psychiatric sequelae of MDMA (ecstasy) and related drugs , 1994, Irish Journal of Psychological Medicine.
[46] K. Dantendorfer,et al. Panic disorder induced by large doses of 3,4-methylenedioxymethamphetamine resolved by paroxetine. , 1998, Journal of clinical psychopharmacology.
[47] G. Ricaurte,et al. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[48] J. Fisk,et al. Working memory deficits in current and previous users of MDMA ('ecstasy'). , 2000, British journal of psychology.
[49] A. Meneses,et al. Modification of 8-OH-DPAT effects on learning by manipulation of the assay conditions. , 1994, Behavioral and neural biology.
[50] H J Eysenck,et al. Sensation seeking in England and America: cross-cultural, age, and sex comparisons. , 1978, Journal of consulting and clinical psychology.
[51] A D Baddeley,et al. Subjective memory assessment and test performance in elderly adults. , 1986, Journal of gerontology.
[52] T. Mieczkowski,et al. Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse. , 1997, Forensic science international.
[53] P. Mcguire,et al. Chronic paranoid psychosis after misuse of MDMA ("ecstasy") , 1991, BMJ.
[54] N. Solowij,et al. Ecstasy use in Australia: patterns of use and associated harm. , 1999, Drug and alcohol dependence.
[55] J. Langston,et al. Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration , 1988, Brain Research.
[56] Y. Shaham,et al. Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans , 1994, Neuropsychopharmacology.
[57] J. Richards,et al. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations. , 1996, The Journal of pharmacology and experimental therapeutics.
[58] Josephine Spiller,et al. Drug misuse declared in 1996: Latest results from the British crime survey: Home office research study 172 , 1997 .
[59] Thomas Fahy,et al. Flashbacks following MDMA , 1992, British Journal of Psychiatry.
[60] C. Robert Cloninger. A systematic method for clinical description and classification of personality variants. A proposal. , 1987, Archives of general psychiatry.
[61] D. Olton,et al. Neurotransmitters and memory: role of cholinergic, serotonergic, and noradrenergic systems. , 1987, Behavioral neuroscience.
[62] T. Shallice. Specific impairments of planning. , 1982, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[63] U. McCann,et al. Memory impairment in abstinent MDMA ("Ecstasy") users , 1998, Neurology.
[64] L. Seiden,et al. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. , 1997, JAMA.
[65] M. Bourin,et al. 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans , 1999, Neuroscience & Biobehavioral Reviews.
[66] U. McCann,et al. Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep. , 1993, Sleep.
[67] H. Curran,et al. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. , 1997, Addiction.
[68] A. Cook. Ecstasy (MDMA): alerting users to the dangers. , 1995, Nursing times.
[69] S. Pallanti,et al. MDMA (Ecstasy) precipitation of panic disorder , 1992, Biological Psychiatry.
[70] A. Buss,et al. An inventory for assessing different kinds of hostility. , 1957, Journal of consulting psychology.
[71] C. Hyde,et al. ‘Ecstasy’ Psychosis and Flashbacks , 1991, British Journal of Psychiatry.
[72] A. Lees,et al. Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits , 1998, Journal of psychopharmacology.
[73] T. Ernst,et al. Cerebral 1H MRS alterations in recreational 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) users , 1999, Journal of magnetic resonance imaging : JMRI.
[74] T. Robinson,et al. Effects of Cortical Serotonin Depletion Induced by 3,4-Methylenedioxymethamphetamine (MDMA) on Behavior, Before and After Additional Cholinergic Blockade , 1993, Neuropsychopharmacology.
[75] F. Graeff. Role of 5-HT in Defensive Behavior and Anxiety , 1993, Reviews in the neurosciences.
[76] H. Klee. Amphetamine Misuse: International Perspectives on Current Trends , 1997 .
[77] M. Spoont. Modulatory role of serotonin in neural information processing: implications for human psychopathology. , 1992, Psychological bulletin.
[78] O. Hornykiewicz. Dopamine (3-hydroxytyramine) and brain function. , 1966, Pharmacological reviews.
[79] S. Peroutka,et al. Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”) , 1990, Journal of neurochemistry.
[80] P. McGuire,et al. Toxic effect of MDMA on brain serotonin neurons , 1999, The Lancet.
[81] Patrick J. O'Donnell,et al. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence , 1999, Psychopharmacology.
[82] M. Morgan. Memory deficits associated with recreational use of “ecstasy” (MDMA) , 1999, Psychopharmacology.
[83] S. Butcher,et al. Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat , 1999, Psychopharmacology.
[84] Tommy Cammock,et al. Development of a More Reliable Version of the Matching Familiar Figures Test. , 1978 .
[85] P. D. Cohen,et al. Licit and illicit drug use in Amsterdam III: developments in drug use 1987 - 1997 / Manja D. Abraham, Peter D.A. Cohen, Roelf-Jan Van Til, & Marieke P.S. Langemeijer , 2000 .
[86] A. Parrott,et al. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance , 1998, Psychopharmacology.
[87] W. Hall,et al. Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug. , 1992, British journal of addiction.
[88] U. McCann,et al. 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans. , 1994, Addiction.
[89] F. Benazzi,et al. Psychiatric illness associated with "ecstasy" , 1991, The Lancet.
[90] M. Morgan. Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity , 1998, Neuropsychopharmacology.
[91] P Bech,et al. The Hamilton Depression Scale , 1981, Acta psychiatrica Scandinavica.
[92] Jörg Daumann,et al. High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users , 2000, Neuropsychopharmacology.
[93] M. Sarter,et al. Involvement of the amygdala in learning and memory: a critical review, with emphasis on anatomical relations. , 1985, Behavioral neuroscience.
[94] B. Yamamoto,et al. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. , 1988, European journal of pharmacology.
[95] F. Schifano,et al. MDMA (“ecstasy”) abuse: Psychopathological features and craving for chocolate: A case series , 1994, Biological Psychiatry.
[96] L. Itti,et al. Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study , 2000, Psychiatry Research: Neuroimaging.
[97] C. J. Schmidt,et al. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. , 1987, The Journal of pharmacology and experimental therapeutics.
[98] G. Battaglia,et al. MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons , 1988, Pharmacology Biochemistry and Behavior.
[99] E. Coccaro. Central Serotonin and Impulsive Aggression , 1989, British Journal of Psychiatry.
[100] J. Spatt,et al. A pure amnestic syndrome after MDMA ("ecstasy") ingestion. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[101] G. Ricaurte,et al. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. , 1992, The Journal of pharmacology and experimental therapeutics.
[102] U. McCann,et al. Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study , 1999, Psychopharmacology.
[103] F. Schifano. Chronic atypical psychosis associated with MDMA ("ecstasy") abuse , 1991, The Lancet.
[104] W. Slikker,et al. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. , 1995, Neurotoxicology and teratology.
[105] Cloninger Cr. A systematic method for clinical description and classification of personality variants: A proposal. , 1987 .
[106] J. Krystal,et al. Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? , 1992, The American journal of drug and alcohol abuse.
[107] M. Colado,et al. 5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p‐chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine , 1993, British journal of pharmacology.
[108] A. Schiff. General Health Questionnaire , 1978, British Journal of Psychiatry.
[109] D. E. Nichols,et al. Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes. , 1982, Journal of medicinal chemistry.
[110] R. Hammersley,et al. Patterns of ecstasy use by drug users , 1999 .
[111] G. Ricaurte,et al. Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery , 1999, The Journal of Neuroscience.
[112] Gerald L. Brown,et al. Aggression in Humans Correlates With Cerebrospinal , 1979 .
[113] Z. Kruk,et al. Direct effects of 3,4‐methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices , 2000, Synapse.
[114] M. Conner,et al. Contents of "ecstasy" , 1995, The Lancet.
[115] F. Vollenweider,et al. Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers , 1998, Neuropsychopharmacology.
[116] R. Noyes,et al. Relationship of generalized anxiety symptoms to urinary 5-hydroxyindoleacetic acid and vanillylmandelic acid , 1995, Psychiatry Research.
[117] Seiden Ls,et al. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. , 1996 .
[118] J. Cummings,et al. Frontal-subcortical circuits and human behavior. , 1993, Journal of psychosomatic research.
[119] J. T. Coull,et al. Tryptophan depletion in normal volunteers produces selective impairments in learning and memory , 1994, Neuropharmacology.
[120] Peter La Cour,et al. Rivermead Behavioural Memory Test , 1990 .
[121] F. Schifano,et al. MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. , 1998, Drug and alcohol dependence.
[122] W. van den Brink,et al. Memory disturbances in ”Ecstasy” users are correlated with an altered brain serotonin neurotransmission , 2000, Psychopharmacology.
[123] G. Greer,et al. Subjective reports of the effects of MDMA in a clinical setting. , 1986, Journal of psychoactive drugs.